verapamil has been researched along with vinpocetine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Burtsev, EM; Savkov, VS; Shprakh, VV | 1 |
| Dorogiĭ, AN; Ishchenko, MM; Nechaĭ, EE; Shkrobot, SI | 1 |
| Akopov, SE; Gabrielian, ES; Sarkisian, SB | 1 |
| Aardal, S; Helle, KB; Lillestłl, IK | 1 |
| Bulaeva, SV; Chuchkanov, FA; Maimistova, AA; Muravyov, AV; Yakusevich, VV; Zaitsev, LG | 1 |
| Horvath, B; Kesmarky, G; Toth, K; Vekasi, J | 1 |
9 other study(ies) available for verapamil and vinpocetine
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
Topics: Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Middle Aged; Phosphodiesterase Inhibitors; Vasodilator Agents; Verapamil; Vinca Alkaloids | 1992 |
[Vasoactive and cardiotonic drugs in the treatment of initial manifestations of cerebrovascular insufficiency in occlusive diseases of major blood vessels of the head].
Topics: Adult; Aged; Aminophylline; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebrovascular Disorders; Drug Therapy, Combination; Humans; Middle Aged; Vasodilator Agents; Verapamil; Vertebral Artery; Vinca Alkaloids | 1991 |
[Approaches to the creation of a model of cerebral thrombocytic microembolism and to research on the effects of drugs].
Topics: Acid-Base Equilibrium; Animals; Blood Pressure; Cats; Collagen; Disease Models, Animal; Drug Evaluation, Preclinical; Epoprostenol; Fibrinolytic Agents; Intracranial Embolism and Thrombosis; Methods; Papaverine; Platelet Aggregation; Vasodilator Agents; Verapamil; Vinca Alkaloids | 1987 |
Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Isradipine; Milrinone; Muscle, Smooth, Vascular; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrrolidinones; Rolipram; Swine; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilation; Verapamil; Vinca Alkaloids | 1998 |
Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: in vitro study.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Blood Viscosity; Caffeine; Calcimycin; Calcium; Egtazic Acid; Erythrocyte Aggregation; Hemorheology; Humans; Male; Nifedipine; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Verapamil; Vinca Alkaloids | 2007 |
In vitro antioxidant properties of pentoxifylline and vinpocetine in a rheological model.
Topics: Adult; Blood Viscosity; Caffeine; Calcimycin; Calcium; Egtazic Acid; Erythrocyte Aggregation; Free Radical Scavengers; Hemorheology; Humans; Male; Nifedipine; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Verapamil; Vinca Alkaloids | 2008 |